However, one study showed that SPARC is negatively correlated with clinical factors of GC and suppressed GC cell metastasis by decreasing MMP-7, MMP-9, N-cadherin, Sp1, and p-ERK1/2 expression [32]. This evidence concerns the gene MAPK3 and gastric cancer.